Trial intelligence / Profile preview

PPIs for Gastroesophageal Variceal Bleeding in Liver Cirrhosis

NCT03175731Phase 4Completed

Start
May 2017
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of pantoprazole in Gastroesophageal varices (GEV) (2 arms). Primary endpoint: Variceal Bleeding Events at 8 weeks. Started May 2017; status: completed.

02

Drugs

pantoprazole
03

Conditions

Gastroesophageal varices (GEV)

Beyond the preview

Go deeper on NCT03175731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03175731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call